CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-15 | Wahl Bryan General Counsel | Option exercise · Restricted Stock Units | −7,175 | 21,527 | ||
| 2025-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise | +21,264 | 87,265 | ||
| 2025-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −5,097 | 5,097 | ||
| 2025-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −8,148 | 16,296 | ||
| 2025-03-15 | Neervannan Seshadri Chief Operating Officer | Option exercise · Restricted Stock Units | −8,019 | 24,060 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise | +20,957 | 75,622 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,790 | 4,790 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −8,148 | 16,296 | ||
| 2025-03-15 | Mottiwala Aziz Chief Commercial Officer | Option exercise · Restricted Stock Units | −8,019 | 24,060 | ||
| 2025-03-07 | Goldberg Andrew D. Director | Option exercise | +7,000 | $12.89 | $90K | 13,350 |
| 2025-03-07 | Goldberg Andrew D. Director | Option exercise · Stock Option (right to buy) | −7,000 | 0 | ||
| 2025-03-05 | Whitfield Dianne C. Chief Human Resources Officer | Grant or award · Stock Option (right to buy) | +30,628 | 30,628 | ||
| 2025-03-05 | Whitfield Dianne C. Chief Human Resources Officer | Grant or award · Restricted Stock Units | +20,089 | 20,089 | ||
| 2025-03-05 | Farrow Jeffrey S See Remarks | Grant or award · Stock Option (right to buy) | +30,628 | 30,628 | ||
| 2025-03-05 | Farrow Jeffrey S See Remarks | Grant or award · Restricted Stock Units | +20,089 | 20,089 | ||
| 2025-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +33,691 | 33,691 | ||
| 2025-03-05 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Restricted Stock Units | +22,098 | 22,098 | ||
| 2025-03-05 | Neervannan Seshadri Chief Operating Officer | Grant or award · Stock Option (right to buy) | +30,628 | 30,628 | ||
| 2025-03-05 | Neervannan Seshadri Chief Operating Officer | Grant or award · Restricted Stock Units | +20,089 | 20,089 | ||
| 2025-03-05 | Wahl Bryan General Counsel | Grant or award · Stock Option (right to buy) | +30,628 | 30,628 |
Page 12 of 13 · 257 trades